Moderna’s COVID-19 vaccine shows 95% efficacy

US company second to report impressive efficacy for its COVID-19 vaccine candidate.

Trial COVID-19 vaccine shown to be 90% effective

Pfizer and BioNTech announce vaccine candidate against COVID-19 achieved success in first interim analysis from Phase 3 study.

Coronaviruses mimic immune proteins and hide in plain sight

New study finds coronaviruses are masters of mimicry, reproducing their host’s immune proteins to remain invisible and help promote infection.

Lipid nanoparticles boost potential vaccine against SARS-CoV-2

Researchers enhance the immune response against the receptor binding domain of SARS-CoV-2 by presenting it on liposomes, providing a promising strategy for vaccine development targeting this domain.

Precaution: A lesson from COVID-19

Measures that could have been taken at the beginning of the pandemic were not implemented as precautionary preparation but rather as reactionary to an already spreading virus, making it hard to contain.

Research highlights

Sign up for our newsletter

Receive the latest science news directly to your inbox once a week.

Have a question or feedback?

Contact the Advanced Science News editorial team at advsciencenews@wiley.com.